Evidence-based Treatment for Low-grade Glioma.


Journal Article (Review)

OBJECTIVES: To identify the tumors included in the WHO classification of low-grade gliomas, and review the importance of molecular biomarkers and their implication for treatment, prognosis, and outcomes. DATA SOURCES: Published research, clinical guidelines, educational articles in oncology journals, and Web-based resources. CONCLUSION: Molecular neuropathology has influenced the reclassification of low-grade gliomas and, as such, has provided patient-specific treatments with improving outcomes. IMPLICATIONS FOR NURSING PRACTICE: Nurses play a key role in patient education and communication with the patient's interdisciplinary care team. Understanding the molecular neuropathology that determine treatment recommendations and in turn recognizing and identifying complications provides improved patient/caregiver satisfaction and outcomes.

Full Text

Duke Authors

Cited Authors

  • Semmel, D; Ware, C; Kim, JY; Peters, KB

Published Date

  • December 2018

Published In

Volume / Issue

  • 34 / 5

Start / End Page

  • 465 - 471

PubMed ID

  • 30391119

Pubmed Central ID

  • 30391119

Electronic International Standard Serial Number (EISSN)

  • 1878-3449

Digital Object Identifier (DOI)

  • 10.1016/j.soncn.2018.10.008


  • eng

Conference Location

  • United States